Bragar Eagel &amp; Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Claritev (CTEV) To Contact Him Directly To Discuss Their Options  If you purchased or acquired stock

CTEV

CLARITEV STOCKHOLDER ALERT: Bragar Eagel & Squire, P.C. is Investigating Claritev Corporation on Behalf of Claritev Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire investigates Claritev (CTEV) after DOJ probe

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>Bragar Eagel &amp;amp; Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Claritev (CTEV) To Contact Him Directly To Discuss Their Options  If you purchased or acquired stock</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>Bragar Eagel &amp; Squire is pursuing potential securities claims against Claritev (CTEV) following reports the DOJ is examining its Data iSight tool. Claritev shares slid about 41% after the May 14 news, underscoring ongoing litigation and regulatory risk. The outcome could influence volatility and valuation if new price-relevant facts emerge.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>Bragar Eagel &amp; Squire investigating Claritev (CTEV) stockholders&#039; claims. For investors.</li><li>DOJ antitrust probe into Claritev&#039;s Data iSight; stock fell ~41%.</li><li>May 14 Capitol Forum report prompted the price drop; legal risk highlighted.</li><li>June 2 Bragar firm invites investors to discuss potential claims; no cost to participate.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>Claritev Corporation (CTEV)</strong>: Subject of DOJ antitrust probe; stock volatility and potential litigation risk.</li></ul>
  </section>

  <section data-block="category">
    <h3>Legal</h3>
    <p>Legal category: regulatory scrutiny and potential securities claims risk surrounding Claritev; aligns with investor-rights firm actions and ongoing DOJ investigation dynamics.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>DOJ antitrust probe into Data iSight pricing tool raises regulatory risk for CTEV.</li><li>CTEV dropped ~41% on May 14-15 after Capitol Forum report; further updates possible.</li><li>Bragar Eagel &amp; Squire&#039;s investigation adds potential shareholder litigation headwind.</li><li>Pricing-tool scrutiny could affect valuation and earnings visibility.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>Claritev Corporation (CTEV) is the subject of the news item.</li><li>May 14, 2026: Capitol Forum reports DOJ antitrust price-fixing investigation into Claritev&#039;s Data iSight pricing tool.</li><li>May 15, 2026: CTEV closes at $13.87, down from $23.47 on May 14 (~41% drop).</li><li>June 2, 2026: Bragar Eagel &amp; Squire announces investigation into potential securities claims on behalf of shareholders.</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>CTEV likely to remain under near-term pressure amid ongoing legal inquiry and potential claims.</p>
  </section>
</section>


<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css"></link><p align="justify"><strong>Bragar Eagel &amp; Squire, P.C. </strong><strong>Litigation Partner </strong><a href="https://www.globenewswire.com/Tracker?data=yjp9lZfEfWZzw7E_4uLjMCb-qFy3b5VJVfDPWD3L9G_-QdCJnImXhmZJMv75MSJ69xpn6NsL-vsWZaDCoBB8cS-YR4Dv6DqaLRU2fuW17IoIOAa-SisRmlqEyO0TVsbk" rel="nofollow" target="_blank"><strong>Brandon Walker</strong></a><strong> Encourages Investors Who Suffered Losses In Claritev (CTEV) To Contact Him Directly To Discuss Their Options</strong></p>  <p align="justify"><strong>If you purchased or acquired stock in </strong><strong>Claritev</strong><strong> and would like to discuss your legal rights, call Bragar Eagel &amp; Squire partner Brandon Walker or Melissa Fortunato directly at (212) 355-4648.</strong></p>  <p align="justify">Click <a href="https://www.globenewswire.com/Tracker?data=KylmjU7o-gqVZv98pPabDdAU9rfzsXhF3enZhV_zpOA8uHv4mhPVRDWgfN1HYmt8RL3kkU9xhyMaqeO79GoTvg==" rel="nofollow" target="_blank">here</a> to participate in the action.</p>  <p align="justify">NEW YORK, June  02, 2026  (GLOBE NEWSWIRE) -- </p>  <p align="justify"><strong>What's Happening:</strong></p>  <ul type="circle"><li style="margin-bottom:12pt; text-align:justify;"><a href="https://www.bespc.com" rel="nofollow" target="_blank">Bragar Eagel &amp; Squire, P.C</a>., a nationally recognized stockholder rights law firm, is investigating potential claims against Claritev Corporation ("Claritev" or the "Company") (NYSE:<a class="ticker" href="https://www.benzinga.com/quote/CTEV">CTEV</a>) on behalf of Claritev stockholders. Our investigation concerns whether Claritev has violated the federal securities laws and/or engaged in other unlawful business practices.<br></br><br></br></li></ul>  <p align="justify"><strong>Investigation Details:</strong></p>  <ul type="circle"><li style="margin-bottom:12pt; text-align:justify;">On May 14, 2026, The Capitol Forum reported that the U.S. Department of Justice's anti-trust division has launched a criminal price-fixing investigation into Claritev. According to the article, officials are talking to third parties and investigating the Company's Data iSight pricing tool. On this news, the price of Claritev shares declined by $9.60 per share, or approximately 41%, from $23.47 per share on May 14, 2026 to close at $13.87 on May 15, 2026.<br></br><br></br></li></ul>  <p align="justify"><strong>Next Steps:</strong></p>  <ul type="circle"><li style="text-align:justify;">If you purchased or otherwise acquired Claritev shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact <a href="https://www.bespc.com/professionals/brandon-walker" rel="nofollow" target="_blank">Brandon Walker</a> or <a href="https://www.bespc.com/professionals/melissa-fortunato" rel="nofollow" target="_blank">Melissa Fortunato</a> by email at <a href="mailto:investigations@bespc.com" rel="nofollow" target="_blank">investigations@bespc.com</a>, by telephone at (212) 355-4648, or by <a href="https://bespc.com/cases/CTEV" rel="nofollow" target="_blank">filling out this contact form</a>. There is no cost or obligation to you.<br></br><br></br></li></ul>  <p align="justify"><strong>About Bragar Eagel &amp; Squire, P.C.:</strong></p>  <p align="justify">Bragar Eagel &amp; Squire, P.C. is a nationally recognized law firm with offices in New York, South Carolina, and California. The firm represents individual and institutional investors in securities, derivative, and commercial litigation as well as individuals in consumer protection and data privacy litigation. The firm has a nationwide practice and routinely handles cases in both federal and state courts. For more information about the firm, please visit <a href="https://www.globenewswire.com/Tracker?data=n2HrI-B1dRpz3PWo4RA5IQKqsWFLqNEIaF9XJ-j0S51vrCnzm4w8sQb39QlwUn6wjLXHxzoMlXYI1JqL8v6pMg==" rel="nofollow" target="_blank">www.bespc.com</a>. Attorney advertising. Prior results do not guarantee similar outcomes.</p>  <p align="justify">Follow us for updates on <a href="https://www.globenewswire.com/Tracker?data=udAcrE6e1TgcHvAXtOxl5VEEn199qxAl862Di81n8PjtymwN4q0o548XdvCgElYl0_IAKJbGhbi-wbAdvwHDujV-eIf4GplV6-CDqveik-fqWm2v073yHqisPGXrVBDp" rel="nofollow" target="_blank">LinkedIn</a> and <a href="https://www.globenewswire.com/Tracker?data=GmvkGUNK48NxMMOLsq05AkQ_fPh4KASajtGsCLpeGip4irVjXS2Sw_3H8HWUlk7bxoEcTEl8KtDfDI37z6OPtFSsIZm2Sx6wmlgni1CG3ScSAE-G1w7GCP0jHw3bfz21" rel="nofollow" target="_blank">Facebook</a>, and keep up with other news by following Brandon Walker, Esq. on <a href="https://www.globenewswire.com/Tracker?data=udAcrE6e1TgcHvAXtOxl5W1eXFeuYNwEMfub0XzUlMlhumrlEV9SNPGlujcrNry1NC5vP84M_SYvzVTjqkE3pvBylrbIQkRdllxkRrkRSu7U__gFm_mbTVEo6-sB3dtH" rel="nofollow" target="_blank">LinkedIn</a>.</p>  <p align="justify"><strong>Contact Information:</strong></p>  <p align="justify">Bragar Eagel &amp; Squire, P.C.<br></br>Brandon Walker, Esq.<br></br>Melissa Fortunato, Esq.<br></br>(212) 355-4648<br></br><a href="https://www.globenewswire.com/Tracker?data=GO4lYgZE9lecidIKCRK_cOReIoO2DPzZJ2qmccitRZCVNoRpfQBzVwWcrpFrYVxGj98SL0nLhUHtfejJtlqJ2bXKVsxmoZamWnXSV58t1trweEgkeclqsATIseUJweA_" rel="nofollow" target="_blank"><u>investigations@bespc.com</u></a><br></br><a href="https://www.globenewswire.com/Tracker?data=n2HrI-B1dRpz3PWo4RA5IUn2guHor0SIY_IFF6g_DhW6bLVFerNpP-B2zHwTC3tkApPc-DRZ7vy0z-WY_CEqBw==" rel="nofollow" target="_blank"><u>www.bespc.com</u></a></p> <img alt="" class="__GNW8366DE3E__IMG" src="https://www.globenewswire.com/newsroom/ti?nf=OTczMDk0NyM3NjM0MDMxIzIxMDAzOTg="></img> <br></br><img alt="" src="https://ml.globenewswire.com/media/NDU2NGUxNjItNTE2Yy00OTI5LTk0OTMtZTdmNjQyMjhiZDVkLTExMTE5NjktMjAyNi0wNi0wMi1lbg==/tiny/Bragar-Eagel-Squire.png" referrerpolicy="no-referrer-when-downgrade"></img><p><a href="https://www.globenewswire.com/NewsRoom/AttachmentNg/29481954-f2ff-4756-b5a9-d982a6497bd0"><img src="https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg" border="0" width="150" height="75" alt="Primary Logo"></img></a></p>

Bragar Eagel & Squire is pursuing potential securities claims against Claritev (CTEV) following reports the DOJ is examining its Data iSight tool. Claritev shares slid about 41% after the May 14 news, underscoring ongoing litigation and regulatory risk. The outcome could influence volatility and valuation if new price-relevant facts emerge.

claritev-stockholder-alert-bragar-eagel-squire-p-c-is-investigating-claritev-corporation-on-behalf-of-claritev-stockholders-and-encourages-investors-to-contact-the-firm

CLARITEV STOCKHOLDER ALERT: Bragar Eagel & Squire, P.C. is Investigating Claritev Corporation on Behalf of Claritev Stockholders and Encourages Investors to Contact the Firm

AI Summary

Sentiment Rationale

Trading Thesis

Market-Moving

Key Facts

Companies Mentioned

Legal

Related News